Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II)

Background Pharmacological options for the treatment of sarcopenia currently do not exist. However, off-label treatment options of some established drugs have been suggested. Objectives The aim of this study was to assess differences in various muscle and physical performance parameters in relation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs & aging 2016-11, Vol.33 (11), p.829-837
Hauptverfasser:	Spira, Dominik, Walston, Jeremy, Buchmann, Nikolaus, Nikolov, Jivko, Demuth, Ilja, Steinhagen-Thiessen, Elisabeth, Eckardt, Rahel, Norman, Kristina
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorptiometry, Photon Aged Aging - drug effects Angiotensin-Converting Enzyme Inhibitors - administration & dosage Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - therapeutic use Berlin Body Composition Body Mass Index Cohort Studies Cross-Sectional Studies Female Geriatrics/Gerontology Hand Strength - physiology Humans Internal Medicine Male Medicine Medicine & Public Health Motor Activity - drug effects Muscle Strength - drug effects Muscle, Skeletal - drug effects Muscle, Skeletal - physiopathology Off-Label Use Organ Size Original Research Article Pharmacology/Toxicology Pharmacotherapy Regression Analysis Risk Factors Sarcopenia - drug therapy Sarcopenia - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!